Rapidly growing, investor-friendly market with significant export potential, backed by government support and a strong focus on innovation and sustainability.
Top 3
Top 3 fastest growing subsectors – Plant Derivatives, Nutraceuticals, Plant Based drugs
8,648
There are 8,648 licensed Ayurvedic, Siddha, Unani and Homoeopathy drug manufacturers in the country
7,55,780
Registered Ayush practitioners, 886 UG Colleges and 251 PG colleges in the Ayush network, 3,859 Ayush hospitals, 37,385 Ayush dispensaries and 8,168 Ayush Health and Wellness Centre.
It stands as a beacon of rapid growth and immense potential within India’s economy. Over the past decade, its manufacturing segment alone has burgeoned from under $3 Bn in 2014 to an impressive $23.3 Bn by 2022, marking an exponential growth trajectory. This surge is underpinned by a robust CAGR of 17% across the industry, with sub-sectors like nutraceuticals and plant derivatives surpassing even these figures. Concurrently, Ayush services have flourished, reaching a valuation of $21.3 Bn, mirroring the sector’s manufacturing prowess. Notably, Ayush has emerged as a global player, as evidenced by its significant exports to key markets such as the USA, EU and UAE, which account for more than half of its total export volume.
The sector’s allure extends beyond economic metrics; it embodies a cultural and wellness renaissance that resonates globally. This is underscored by burgeoning interest and investments from diverse global quarters, spanning Southeast Asia to North America and Europe. Furthermore, Ayush’s growth story is distinctly inclusive, powered largely by MSMEs and startups, which constitute over 80% of the sector’s entities. These startups, which are frequently located in Tier-2 and Tier-3 cities, signify a democratization of entrepreneurship and a deep-rooted cultural heritage that meets modern entrepreneurial zeal. Moreover, with a substantial presence of women entrepreneurs—comprising 55% of startup leadership—the sector not only promotes economic growth but also social empowerment.
Looking ahead, the Ayush sector is poised for even greater strides, buoyed by post-pandemic lifestyle shifts towards holistic health and heightened global recognition. Initiatives such as the Ayush Visa and endorsements from global platforms like the G20 and WHO underscore its growing stature and promise. As the industry matures, fostering innovation and nurturing startups will be pivotal to harnessing its full potential. The coming decade holds immense promise for Ayush startups to not only lead domestically but also emerge as global champions, steering this ancient yet dynamic sector into a new era of prosperity and prominence on the world stage.
India is the second-highest producer of medicinal herbs in the world after China.
Ayurveda is acknowledged as a system of traditional medicine in more than 30 countries.
India ranks 7th in the global wellness economy, with a market size of $132.5 Bn in 2022. India’s medical tourism attracts 2 million patients annually from 78 countries.
The number of MSMEs in the Ayush industry has risen by nearly 40%, from 38,216 in August 2021 to 53,023 by January 2023, demonstrating significant growth and potential.
Provides updated operational guidelines for the Indian...
Updated guidelines for the Central Sector Scheme...
Updated guidelines for the International Cooperation (IC)...
Updated operational guidelines outlining the framework, eligibility,...
Central Sector Scheme providing Information, Education, and...
Outlines initiatives and guidelines to promote research,...
Updated guidelines for the National Medicinal Plants...

A Government of India strategy to position...

Outlines the framework, objectives, and implementation strategy...

Central Sector Scheme to improve quality, production...